Empowered Funds LLC Sells 14,909 Shares of Cardinal Health, Inc. $CAH

Empowered Funds LLC reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.9% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 78,652 shares of the company’s stock after selling 14,909 shares during the quarter. Empowered Funds LLC’s holdings in Cardinal Health were worth $13,173,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CAH. MassMutual Private Wealth & Trust FSB increased its position in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after acquiring an additional 62 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after purchasing an additional 69 shares during the last quarter. Perigon Wealth Management LLC increased its holdings in shares of Cardinal Health by 3.2% in the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after purchasing an additional 72 shares in the last quarter. Community Bank & Trust Waco Texas increased its holdings in shares of Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after purchasing an additional 74 shares in the last quarter. Finally, Atlantic Edge Private Wealth Management LLC raised its stake in shares of Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.5%

Shares of NYSE:CAH opened at $207.18 on Wednesday. The stock has a market capitalization of $49.22 billion, a PE ratio of 32.12, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The firm’s 50 day moving average price is $167.82 and its 200-day moving average price is $160.05. Cardinal Health, Inc. has a twelve month low of $114.60 and a twelve month high of $208.32.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the previous year, the business posted $1.88 earnings per share. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Analysts Set New Price Targets

Several research firms recently commented on CAH. Jefferies Financial Group set a $220.00 price objective on Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Argus raised their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Evercore ISI lifted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $206.46.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.